Why Is Core Laboratories (CLB) Down 5.9% Since Last Earnings Report?

Core Laboratories Overview - Core Laboratories shares have decreased by approximately 5.9% over the past month, underperforming the S&P 500 [1] - The most recent earnings report is essential for understanding the key drivers affecting the stock [1] Earnings Estimates - Estimates for Core Laboratories have remained flat over the past month [2] VGM Scores - Core Laboratories has an average Growth Score of C, a Momentum Score of D, and a Value Score of C, placing it in the middle 20% for the value investment strategy [3] Outlook - Core Laboratories holds a Zacks Rank of 4 (Sell), indicating expectations for below-average returns in the upcoming months [4] Industry Comparison - Core Laboratories is part of the Zacks Oil and Gas - Field Services industry, where competitor Baker Hughes has seen a slight gain of 0.6% over the past month [5] - Baker Hughes reported revenues of $6.43 billion for the last quarter, reflecting a year-over-year increase of 0.1%, with EPS rising from $0.43 to $0.51 [5] - For the current quarter, Baker Hughes is projected to report earnings of $0.55 per share, a decrease of 3.5% from the previous year, with a Zacks Consensus Estimate revision of -7% over the last 30 days [6]